230 related articles for article (PubMed ID: 31605350)
1. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
Yuan Y; Hong HG; Chen LQ
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Nodal Skip Metastasis Is Associated with Survival Benefit in Thoracic Esophageal Squamous Cell Carcinoma.
Yang YS; Shang QX; Yuan Y; Chen LQ
Ann Surg Oncol; 2021 Oct; 28(11):6353-6354. PubMed ID: 33543386
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Using Efficacy Index to Clarify the Clinical Value of Each Lymph Node Station for Esophageal Squamous Cell Carcinoma.
Nie X; Li K; Peng L; Leng X
Ann Surg Oncol; 2023 Sep; 30(9):5866-5867. PubMed ID: 37322279
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Sep; 28(9):4867-4868. PubMed ID: 33492541
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma.
Kumakura Y; Yokobori T; Sohda M; Shirabe K; Kuwano H
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):741-742. PubMed ID: 30315381
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kim DJ; Kim HE
Ann Surg Oncol; 2022 Aug; 29(8):4918-4919. PubMed ID: 35419759
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Esophageal Squamous Cell Carcinoma-Still a Conundrum.
Squires MH; Salo JC
Ann Surg Oncol; 2022 Feb; 29(2):1334-1335. PubMed ID: 34674090
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma.
Nakamura S; Kanda M; Kodera Y
Ann Surg Oncol; 2020 Jul; 27(7):2569-2570. PubMed ID: 32166595
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.
Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
Ann Surg Oncol; 2023 Apr; 30(4):2186-2187. PubMed ID: 36538253
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: NADPH Oxidase 2 has Potential as a Therapeutic Target for Esophageal Squamous Cell Carcinoma.
Shimizu H; Katsurahara K; Inoue H; Shiozaki A; Otsuji E
Ann Surg Oncol; 2022 Dec; 29(13):8688-8689. PubMed ID: 35986132
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Treatment Strategies for Locally Advanced Borderline Resectable Esophageal Squamous Cell Carcinoma.
Hong Y
Ann Surg Oncol; 2024 Feb; 31(2):896. PubMed ID: 37962739
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Optimizing Proximal Esophageal Squamous Cell Carcinoma Treatment.
Patel DC; Berry MF
Ann Surg Oncol; 2023 Feb; 30(2):828-829. PubMed ID: 36258059
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?
Morimoto Y; Matsuda S; Kawakubo H; Nakamura K; Kobayashi R; Hisaoka K; Okui J; Takeuchi M; Aimono E; Fukuda K; Nakamura R; Saya H; Nishihara H; Kitagawa Y
Ann Surg Oncol; 2023 Jun; 30(6):3757-3758. PubMed ID: 36807023
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus.
Kanda M; Koike M; Kodera Y
Ann Surg Oncol; 2020 Sep; 27(9):3206-3207. PubMed ID: 32246315
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study.
Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
Ann Surg Oncol; 2023 Sep; 30(9):5895-5896. PubMed ID: 37266806
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer.
Ohkura Y
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):703-704. PubMed ID: 30251022
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: The Role of Robot-Assisted Ivor Lewis Esophagectomy for Esophageal Cancer.
Zhang Y; Li H
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):594-595. PubMed ID: 31025227
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Implementation of Age and Co-morbidity in the Treatment Guideline of Patients with Esophageal Squamous Cell Carcinoma.
Faiz Z; Plukker JTM
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):585-586. PubMed ID: 31011909
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
Suzuki T; Okamura A; Watanabe M; Chin K
Ann Surg Oncol; 2020 May; 27(5):1518-1519. PubMed ID: 32108921
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
Deng W; Chen J; Xiao Z
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
